Kneidinger N, Valtin C, Hettich I, Frye BC, et al. Five-year Outcome of an Early Everolimus-based Quadruple Immunosuppression in Lung Transplant Recipients: Follow-up of the 4EVERLUNG Study. Transplantation 2022;106:1867-1874.
PMID: 35283454